Breaking News Instant updates and real-time market news.

BOLD

Audentes Therapeutics

$24.65

0.36 (1.48%)

09:23
01/11/19
01/11
09:23
01/11/19
09:23

Audentes Therapeutics upgraded to Buy at Guggenheim on positive AT132 outlook

As reported earlier, Guggenheim analyst Whitney Ijem upgraded Audentes Therapeutics to Buy from Neutral with a price target of $35 at the conclusion of the JPMorgan Healthcare conference this week. The analyst says that he is "incrementally more positive" on the company's A132 program after the meeting, anticipating "productive regulatory and data updates in the near term." Ijem further expects 2019 to be a year of of "pipeline progress" for Audentes Therapeutics now that the Pompe program is "back on track" and ahead of more details about a larger neuromuscular indication.

BOLD Audentes Therapeutics
$24.65

0.36 (1.48%)

11/07/18
WBLR
11/07/18
DOWNGRADE
WBLR
Market Perform
Audentes downgraded to Market Perform from Outperform at William Blair
William Blair analyst Raju Prasad downgraded Audentes Therapeutics to Market Perform following the company's Q3 results. The analyst says increased competition in Pompe disease is giving him pause.
11/07/18
11/07/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Freeport McMoRan (FCX) downgraded to Underperform from Sector Perform at RBC Capital with analyst Stephen Walker saying he points to the company's premium valuation ahead of what he expects to be a decline in 2019 production. 2. Zillow (Z, ZG) downgraded to Sell from Hold at Zelman and to Negative from Neutral at Susquehanna. 3. Mindbody (MB) downgraded to Neutral from Buy at UBS and Roth Capital as well as to Neutral from Overweight at JPMorgan. 4. Frontier Communications (FTR) downgraded to Sell from Neutral at UBS with analyst Batya Levi saying Frontier's free cash flow remains under pressure. 5. Audentes downgraded to Market Perform from Outperform at William Blair with analyst Raju Prasad saying increased competition in Pompe disease is giving him pause. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
11/26/18
JPMS
11/26/18
INITIATION
Target $35
JPMS
Overweight
Audentes Therapeutics initiated with an Overweight at JPMorgan
JPMorgan analyst Anupam Rama started Audentes Therapeutics with an Overweight rating and $35 price target. The stock has pulled 40% since early October, which represents an attractive long-term entry point, Rama tells investors in a research note. He believes the "de-risked nature" of the known clinical data for gene therapy lead assets AT132 in X-Linked Myotubular Myopathy and AT342 in Crigler-Najjar Syndrome "goes underappreciated" at current share levels.
01/11/19
GUGG
01/11/19
UPGRADE
GUGG
Buy
Audentes Therapeutics upgraded to Buy from Neutral at Guggenheim

TODAY'S FREE FLY STORIES

FISV

Fiserv

$80.62

2.32 (2.96%)

, FDC

First Data

$23.73

0.66 (2.86%)

07:44
01/24/19
01/24
07:44
01/24/19
07:44
Upgrade
Fiserv, First Data rating change  »

Fiserv upgraded to…

FISV

Fiserv

$80.62

2.32 (2.96%)

FDC

First Data

$23.73

0.66 (2.86%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

ATVI

Activision Blizzard

$46.01

-1.03 (-2.19%)

07:43
01/24/19
01/24
07:43
01/24/19
07:43
Recommendations
Activision Blizzard analyst commentary  »

Activision Blizzard price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 12

    Feb

AAL

American Airlines

$31.57

-1.18 (-3.60%)

07:41
01/24/19
01/24
07:41
01/24/19
07:41
Hot Stocks
American Airlines reports Q4 PRASM up 1.4% »

Continued strength in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

ERMAY

Eramet

$0.00

(0.00%)

07:41
01/24/19
01/24
07:41
01/24/19
07:41
Downgrade
Eramet rating change  »

Eramet downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EIX

Edison International

$54.93

0.75 (1.38%)

07:41
01/24/19
01/24
07:41
01/24/19
07:41
Recommendations
Edison International analyst commentary  »

Edison International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FANH

Fanhua

$23.74

1.22 (5.42%)

07:40
01/24/19
01/24
07:40
01/24/19
07:40
Hot Stocks
Fanhua announces correction to January 22 press release »

Fanhua announced a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAL

American Airlines

$31.57

-1.18 (-3.60%)

07:40
01/24/19
01/24
07:40
01/24/19
07:40
Hot Stocks
American Airlines sees Q1 TRASM flat to up approximately 2.0% y/y »

American expects its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

ASND

Ascendis Pharma

$73.16

-0.47 (-0.64%)

07:40
01/24/19
01/24
07:40
01/24/19
07:40
Upgrade
Ascendis Pharma rating change  »

Ascendis Pharma upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

THLEF

Thales

$0.00

(0.00%)

07:40
01/24/19
01/24
07:40
01/24/19
07:40
Downgrade
Thales rating change  »

Thales downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DUAVF

Dassault Aviation

$0.00

(0.00%)

07:40
01/24/19
01/24
07:40
01/24/19
07:40
Downgrade
Dassault Aviation rating change  »

Dassault Aviation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAL

American Airlines

$31.57

-1.18 (-3.60%)

07:39
01/24/19
01/24
07:39
01/24/19
07:39
Earnings
Breaking Earnings news story on American Airlines »

American Airlines sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

TXN

Texas Instruments

$95.49

-1.05 (-1.09%)

07:38
01/24/19
01/24
07:38
01/24/19
07:38
Recommendations
Texas Instruments analyst commentary  »

Citi sees 'multiple…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

CSFL

CenterState Bank

$24.09

0.32 (1.35%)

07:36
01/24/19
01/24
07:36
01/24/19
07:36
Recommendations
CenterState Bank analyst commentary  »

Brean Capital says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Feb

HUBS

HubSpot

$152.02

0.36 (0.24%)

07:36
01/24/19
01/24
07:36
01/24/19
07:36
Downgrade
HubSpot rating change  »

HubSpot downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

MCHP

Microchip

$74.31

-0.9 (-1.20%)

07:36
01/24/19
01/24
07:36
01/24/19
07:36
Downgrade
Microchip rating change  »

Microchip downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

VIVO

Meridian Bioscience

$16.77

0.2 (1.21%)

07:36
01/24/19
01/24
07:36
01/24/19
07:36
Earnings
Meridian Bioscience reports Q4 EPS 20c, consensus 17c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 24

    Jan

AAXN

Axon

$48.06

-0.61 (-1.25%)

07:36
01/24/19
01/24
07:36
01/24/19
07:36
Hot Stocks
Axon receives Taser 7 orders from Florida Police Departments »

Axon received significant…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

CHCO

City Holding

$69.91

-0.09 (-0.13%)

07:35
01/24/19
01/24
07:35
01/24/19
07:35
Earnings
City Holding reports Q4 EPS 68c, consensus $1.24 »

Highlights of the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAL

American Airlines

$31.57

-1.18 (-3.60%)

07:34
01/24/19
01/24
07:34
01/24/19
07:34
Earnings
American Airlines reports Q4 adj. EPS $1.04, consensus $1.01 »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

MMYT

MakeMyTrip

$24.36

(0.00%)

07:34
01/24/19
01/24
07:34
01/24/19
07:34
Earnings
MakeMyTrip reports Q3 adjusted EPS (14c), consensus (37c) »

Reports Q3 adjusted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

EVRI

Everi Holdings

$6.94

0.04 (0.58%)

07:34
01/24/19
01/24
07:34
01/24/19
07:34
Hot Stocks
Everi Holdings extends employment agreement of President and CEO Michael Rumbolz »

Everi Holdings, announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GRUB

GrubHub

$74.46

-0.12 (-0.16%)

07:34
01/24/19
01/24
07:34
01/24/19
07:34
Recommendations
GrubHub analyst commentary  »

GrubHub price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

FANH

Fanhua

$23.74

1.22 (5.42%)

07:33
01/24/19
01/24
07:33
01/24/19
07:33
Hot Stocks
Fanhua completes extended repurchase program, reports new issuance »

Fanhua announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HBAN

Huntington Bancshares

$13.56

0.05 (0.37%)

07:33
01/24/19
01/24
07:33
01/24/19
07:33
Earnings
Huntington Bancshares sees FY19 revenue up approximately 4%-7% »

FY19 consensus $4.77B.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

WBS

Webster Financial

$54.34

0.19 (0.35%)

07:32
01/24/19
01/24
07:32
01/24/19
07:32
Earnings
Webster Financial reports Q4 EPS $1.05, consensus 98c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.